DE0007164600 (DE0007164600)

$168.9B
Market Cap
23.7
P/E Ratio
0.69
Beta
1.70%
Dividend Yield
Piotroski 8/9Altman Z 6.0 SafeBeneish M -2.60 CleanROIC−WACC +7.0%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 6.0 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency exhibits robust fundamentals, characterized by a 16.1% ROIC that generates a substantial +7.0% spread over the cost of equity, indicating significant value creation potential relative to risk. This high return is underpinned by exceptional profitability metrics, specifically a net margin of 19.5% and an industry-leading gross margin of 72.9%, suggesting strong pricing power or low variable costs rather than leverage-driven returns. The quality of earnings appears highly credible given the Piotroski F-Score of 8/9, which signals strong financial health with only one potential weakness, while the Altman Z-Score of 6.0 and Beneish M-Score of -2.60 further corroborate a low probability of distress or manipulation, painting a picture of a financially resilient entity with sustainable operational leverage.

Valuation analysis reveals a current P/E multiple of 23.7x that must be contextualized against historical norms and sector peers to determine if the premium is warranted by future growth trajectories. While the DCF model implies a fair value of $288, this figure encapsulates specific assumptions regarding terminal growth rates and discount factors; any deviation in these inputs could materially alter the intrinsic valuation gap relative to market price. The 7.7% year-over-year revenue growth provides the top-line momentum necessary to support the current multiple, yet investors must assess whether the market is pricing in accelerated expansion or simply rewarding the company's superior margin profile and capital efficiency without demanding a significant premium for future acceleration.

The risk-reward landscape appears favorable based on fundamental metrics, as the combination of high margins and low distress scores typically correlates with lower idiosyncratic volatility compared to growth-at-any-cost peers. However, the absence of sector-specific valuation benchmarks or historical P/E ranges limits the ability to definitively characterize whether the 23.7x multiple represents a discount, parity, or premium within its peer group. Without data on Fama-French alpha factors or recent insider trading activity, the primary uncertainty revolves around the sustainability of maintaining these elevated margins as revenue expands at a moderate 7.7% clip rather than explosively higher rates.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →7%9%11%
2%$361$253$193
3%$440$288$212
4%$571$337$236

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=9.0%, terminal growth 3%. Fair value $288 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
6.0
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.60
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

72.9%
Gross Margin
19.5%
Net Margin
16.1%
ROIC
9.0%
WACC
ROIC − WACC Spread: +7.0%— Positive value creation spread.
+7.7%
Revenue Growth (YoY)
+129.2%
Earnings Growth (YoY)
8.4B
Free Cash Flow
33%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.56x
Debt / Equity
1.16x
Current Ratio
21.9x
Interest Coverage
-0.3x
Net Debt / EBITDA
5.11%
FCF Yield
12.1B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.29
Act: $1.44
+11.9%
Q3
✓ Beat
Est: $1.45
Act: $1.50
+3.8%
Q2
✓ Beat
Est: $1.50
Act: $1.59
+5.7%
Q1
✓ Beat
Est: $1.51
Act: $1.62
+7.6%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.0
Forward P/E
PEG Ratio
3.79
Price/Book
3M
Avg Volume
$273.55
52W High
$143.52
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.8B
Tracked Passive Exposure
6
ETFs Holding DE0007164600
0.74%
Avg Weight in ETFs
$385B
Total ETF AUM

When investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell DE0007164600 shares regardless of DE0007164600's individual fundamentals. We estimate $2.8B of passive capital is structurally linked to DE0007164600 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in DE0007164600 to visualize passive redemption contagion across ETFs and collateral stocks.

DE0007164600 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
DE0007164600EpicenterIEFAETFEFAETFSCHFETFNL0010273215Low RiskCH0012032048Low RiskNVDALow RiskCH0012005267Low RiskAAPLLow Risk
DE0007164600 Price Drop (%)0

If DE0007164600 (DE0007164600) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with DE0007164600. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

DE0007164600 Ownership Dynamics

Ticker
DE0007164600

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

DE0007164600 Capital Efficiency

How efficiently does DE0007164600 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$8.4B
EBITDA
$12.1B
FCF Conversion
70%
Reinvestment Rate
30%
70% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
16.1%
ROIC − WACC Spread
7.0%

DE0007164600 converts 70% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 7.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare DE0007164600 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.